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J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5 B203intention-to-treat.Astandardpair-wisemeta-analysiswascarriedoutusinga
DerSimonian-Lairdrandomeffectsmodel.Riskdistributionwasexpressedas
odds ratio (OR) and 95% conﬁdence interval (CI). Heterogeneity was graded
using I2 statistic. Trial sequential analysis is similar to interim analyses in a
single trial, where monitoring boundaries are used to decide whether a trial
could be terminated early when a p value is sufﬁciently small. Monitoring
boundaries were generated using the O’Brien-Fleming a-spending and the
required diversity adjusted information size was estimated.
RESULTS Six randomized trials (1,161 patients) were included in this
meta-analysis. Pooled estimate tended to favor DES but the difference
was not signiﬁcant (OR 0.66, 95% CI 0.33-1.31, p ¼ 0.235). Heteroge-
neity was moderate (I2 ¼ 56%). At trial sequential analysis, the cu-
mulative z-curve did not cross the traditional boundary (1.96
cumulative Z-Score) and the trial sequential monitoring boundary (a-
spending adjusted 95% CI 0.26-1.66), but neither futility boundary
was overlapped indicating that, adding patients to the comparison,
DES could produce a 50% relative risk reduction in 12-month TLR. The
anticipated number of patients required was 1,871.
CONCLUSIONS DES may have superior anti-restenotic efﬁcacy
compared with DCB, but the difference is not signiﬁcant. Trial
sequential analysis advices that an adjusted number of 1,871 patients
is required to show a signiﬁcant TLR risk reduction with DES and,
since futility boundary are not crossed, conﬁrms that adding patients
to this comparison the difference can became signiﬁcant.
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BACKGROUND Signiﬁcant unprotected left main coronary artery ste-
nosis (ULMCA) is an accepted indication for coronary artery bypass
grafting (CABG). However CABG is no option in a number of clinical
conditions. Percutaneous coronary intervention (PCI) can be performedeven under these unfavorable conditions. We sought to describe the
procedural characteristics and 5-year outcomes of the non-selected
population undergoing ULMCA PCI at our tertiary care Institution.
METHODS All consecutive patients undergoing UL PCI at the Hun-
garian Institute of Cardiology between Jan. 1, 2007 and Dec. 31, 2008
are included in this study. The choice of devices including stents (bare
metal or drug eluting (DES) stents), stenting strategy (single or two-
stent technique) and the use of intraaortic balloon pumps were left to
the discretion of the operator. 5-year follow-up data concerning sur-
vival, myocardial infarction (MI), repeat revascularization and
recoronary angiography were collected using the institutional data-
base, contacting the patients, their families, other hospitals and the
National Health Insurance database.
RESULTS 76 patients underwent ULMCAPCI at our Institution during the
study period. Their baseline clinical characteristics are shown in Table 1.
The indication for ULMCA PCI was angina pectoris in 18 (24%), non-ST-
segment elevation acute coronary syndrome (ACS) in 32 (42%), ST-eleva-
tionmyocardial infarction in 11 (14,5%), cardiogenic shock caused byMI in
13 (17%) and heart failure not related to ACS in 2 cases (2,5%). 61 patients
(80%) received a DES in ULMCA. No patient suffered a peri-procedural MI
or stroke. 30-day mortality was 14,5%, 5-year mortality 50%. In ROC
analysis, EuroSCORE II was the best predictor of 5-year survival (AUC
0,727). Survival according to different SYNTAX score tertiles was not
signiﬁcantly different. 2 suffered a fatal MI, 3 patients had a non-fatal MI
during follow-up. 3 patients had signiﬁcant in-stent restenosis (ISR) in
ULMCAall successfully treated by rePCI. Another 11 patients had rePCI and
3 CABG because of non-ULMCA ISR. Inmultivariate analysis,male gender,
age, GFR, presence of diabetes mellitus and SYNTAX score emerged as
independent predictors of 5-year event free survival. There was no acute
stent thrombosis, we had one probable subacute stent thrombosis, one
deﬁnite late stent thrombosis in the LAD (but not in the ULMCA) and one
possible very late stent thrombosis.Age, years  SD [IQR] 70,1  11,4 [61,8-78,2]
Male (%) 42 (55)Hypertension (%) 62 (82)Diabetes mellitus (%) 25 (33)Dyslipidemia (%) 54 (71)Previous myocardial infarction (%) 23 (30)Previous PCI (%) 12 (16)Previous CABG (%) 7 (9)LVEF on echo, %  SD [IQR] 45  14 [35-55]
EuroSCORE II  SD [IQR] 14,81  17,27 [2,8-26,2]
Additive EuroSCORE  SD [IQR] 10,2  4,6 [7-15]
Logistic EuroSCORE  SD [IQR] 25,25  23,80 [6,1-47,9]
ACEF score  SD [IQR] 1,82  0,82 [1,2-2,3]
GFR, ml/min/1,73m2 SD [IQR] 61,9  29,5 [41,9-82,8]
SYNTAX score  SD [IQR] 27,3  12,2 [17-37,5]CONCLUSIONS ULMCA PCI can be applied with good long-term re-
sults in patients who cannot undergo CABG because of the clinical
scenario, comorbidities or advanced age. The clinical presentation and
downstream disease have a major inﬂuence on the 5-year outcome of
the patients.
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BACKGROUND Stent fracture (SF) is a rarely reported complication of
percutaneous coronary interventions (PCI). It is more commonly re-
ported with older generation stents particularly the sirolimus eluting
stent. We sought to deﬁne our experience and outcome of subjects
presenting to our center with SF.
METHODS We identiﬁed all mention of the term ’stent fracture’ from all
reports in the cardiac catheterization laboratory database over a 10 year
period, from 2006 to 2015 (ﬁrst quarter). All coronary SF were identiﬁed.
Subjects who refused authorization for use of their medical record in
researchwereexcluded.Themedical recordandcoronaryangiogramsof the
remainderwere reviewed. This studywas approvedby theMayoClinic IRB.
RESULTS 16 patients with 18 SF events were identiﬁed at median age of
62.0 (IQR 48.1-71.2) years, 0.6 (IQR 0.3-1.7) years after stent implantation;
